title: Secretory component mRNA and protein expression in colorectal adenomas and carcinomas.
abstract: Secretary component (SC) is expressed basolaterally as a transmembrane protein (pIg receptor) on secretory epithelial cells. As pIg receptor it plays a central role in humoral immunity by mediating the external translocation of dimeric IgA and pentameric IgM. A few case reports have suggested that reduced or absent SC protein expression is associated with diarrhoeal disease, but there is no convincing evidence that a primary pIg receptor deficiency can occur. In this study the relative presence of SC mRNA was determined by Northern blot analysis and related to immunohistochemically determined SC protein expression in 33 colorectal adenomas (31 patients) with increased risk of developing sporadic colorectal cancer, as well as in 19 colorectal carcinomas from 19 patients with such sporadic tumours. In the adenomas, SC mRNA levels were positively related to SC protein expression; both mRNA and SC protein were negatively related to histological grade. Similarly, SC mRNA levels tended to be related to the SC protein expression in the carcinomas. SC mRNA was detected in all adenomas, and only two of ten carcinomas (10.5%) deemed to be SC deficient by immunohistochemistry also lacked SC mRNA expression, suggesting diallelic alterations in the SC-encoding gene (locus PIGR). This possibility agreed with Southern blot analysis performed on a separate sample of 32 other colonic carcinomas in which the diallelic loss of D1S58 (which exhibits a close linkage centromerically to PIGR) was calculated to be 6.4%. Together these findings suggested that reduced SC protein expression in colorectal adenomas might be a transcriptional defect reflecting the degree of cellular dysplasia, whereas absent SC protein expression in colorectal carcinomas might also involve post-transcriptional defects and occasional diallelic gene deletions representing late events in carcinogenesis.
authors.affiliation: Laboratory for Immunohistochemisty and Immunopathology (LIIPAT), Institute of Pathology, Rikshospitalet, University of Oslo, Norway.
authors.forename: P
authors.initials: P
authors.lastname: Krajci
authors.forename: G I
authors.initials: GI
authors.lastname: Meling
authors.forename: S N
authors.initials: SN
authors.lastname: Andersen
authors.forename: B
authors.initials: B
authors.lastname: Hofstad
authors.forename: M H
authors.initials: MH
authors.lastname: Vatn
authors.forename: T O
authors.initials: TO
authors.lastname: Rognum
authors.forename: P
authors.initials: P
authors.lastname: Brandtzaeg
mesh_terms: D000236:Adenoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D015139:Blotting, Southern; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D015179:Colorectal Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male; D008875:Middle Aged; D012150:Polymorphism, Restriction Fragment Length; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D012635:Secretory Component / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D012333:RNA, Messenger; D012635:Secretory Component